PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2007 | 54 | 1 |

Tytuł artykułu

The effect of indole-3-carbinol on the expression of CYP1A1, CYP1B1 and AhR genes and proliferation of MCF-7 cells

Warianty tytułu

Języki publikacji

EN

Abstrakty

EN
The influence of an antiestrogen, indole-3-carbinol (I3C) on the expression of CYP1A1, CYP1B1 and AhR genes was investigated in an attempt to establish whether I3C could increase the expression of genes involved in estrone metabolism. Another purpose was to examine the proliferation of an estrogen-dependent breast cancer cell (MCF-7 line) under the influence of I3C and both I3C and DDT. In MCF-7 cells incubated with I3C or I3C and DDT combined, quantitative RT-PCR analysis revealed a significant increase in the level of CYP1A1, AhR, and CYP1B1 transcripts. The proliferation rate of MCF-7 cells was increased by treatment with DDT or estradiol (E2), whereas I3C did not affect the proliferation of MCF-7 cells but greatly reduced the stimulatory effect of DDT, and abolished the effect of E2. The level of p21 transcript, encoding p21 protein involved in the cell cycle, was increased several-fold by I3C comparing to its level in cells incubated with estradiol or DDT. The results suggest that the proliferation of MCF-7 cells is accompanied not only by expression of genes encoding cytochromes involved in estrogen metabolism, but also by changes in the expression of other genes including that encoding p21 protein involved in the cell cycle.

Wydawca

-

Rocznik

Tom

54

Numer

1

Opis fizyczny

p.113-117,fig.,ref.

Twórcy

  • University of Medical Sciences, Swiecickiego 6, 60-781 Poznan, Poland
autor
autor

Bibliografia

  • Angus WG, Larsen MC, Jefcoate CR (1999) Expression of CYP1A1 and CYP1B1 depends on cell-specific factors in human breast cancer cell lines: role of estrogen receptor status. Carcinogenesis 20: 947–955.
  • Bradlow HL, Sepkovic DW, Telang NT, Osborne MP (1999) Multifunctional aspects of the action of indole-3- carbinol as an antitumor agent. Ann N Y Acad Sci 889: 204–213.
  • Brockdorff BL, Skouv J, Reiter BE, Lykkesfeldt AE (2000) Increased expression of cytochrome p450 1A1 and 1B1 genes in anti-estrogen-resistant human breast cancer cell lines. Int J Cancer 88: 902–906.
  • Bustin SA (2002) Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol 29: 23–39.
  • Cariou S, Donovan JC, Flanagan WM, Milic A, Bhattacharya N, Slingerland JM (2000) Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogenmediated cell cycle arrest in human breast cancer cells. Proc Natl Acad Sci USA 97: 9042–9046.
  • Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936–942.
  • Chen I, McDougal A, Wang F, Safe S (1998) Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane. Carcinogenesis 19: 1631–1639.
  • Chomczynski P (1993) A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15: 532–534, 536–537.
  • Coumoul X, Diry M, Robillot C, Barouki R (2001) Differential regulation of cytochrome P450 1A1 and 1B1 by a combination of dioxin and pesticides in the breast tumor cell line MCF-7. Cancer Res 61: 3942–3948.
  • Cover CM, Hsieh SJ, Tran SH, Hallden G, Kim GS, Bjeldanes LF, Firestone GL (1998) Indole-3-carbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signaling. J Biol Chem 273: 3838–3847.
  • Diel P, Olff S, Schmidt S, Michna H (2002) Effects of the environmental estrogens bisphenol A, o,p’-DDT, p-tertoctylphenol and coumestrol on apoptosis induction, cell proliferation and the expression of estrogen sensi tive molecular parameters in the human breast cancer cell line MCF-7. J Steroid Biochem Mol Biol 80: 61–70.
  • Firestone GL, Bjeldanes LF (2003) Indole-3-carbinol and 3-3’-diindolylmethane antiproliferative signaling pathways control cell-cycle gene transcription in human breast cancer cells by regulating promoter–Sp1 transcription factor interactions. J Nutr 133 (Suppl): 2448S– 2455S.
  • Foster JS, Henley DC, Ahamed S, Wimalasena J (2001) Estrogens and cell-cycle regulation in breast cancer. Trends Endocrinol Metab 12: 320–327.
  • Hellmold H, Rylander T, Magnusson M, Reihner E, Warner M, Gustafsson JA (1998) Characterization of cytochrome P450 enzymes in human breast tissue from reduction mammaplasties. J Clin Endocrinol Metab 83: 886–895.
  • Horn TL, Reichert MA, Bliss RL, Malejka-Giganti D (2002) Modulations of P450 mRNA in liver and mammary gland and P450 activities and metabolism of estrogen in liver by treatment of rats with indole-3-carbinol. Biochem Pharmacol 64: 393–404.
  • Iscan M, Klaavuniemi T, Coban T, Kapucuoglu N, Pelkonen O, Raunio H (2001) The expression of cytochrome P450 enzymes in human breast tumours and normal breast tissue. Breast Cancer Res Treat 70: 47–54.
  • Jaga K, Brosius D (1999) Pesticide exposure: human cancers on the horizon. Rev Environ Health 14: 39–50.
  • Jefcoate CR, Liehr JG, Santen RJ, Sutter TR, Yager JD, Yue W, Santner SJ, Tekmal R, Demers L, Pauley R, Naftolin F, Mor G et al. (2000) Tissue-specific synthesis and oxidative metabolism of estrogens. J Natl Cancer Inst Monogr 27: 95–112.
  • Jellinck PH, Forkert PG, Okey AB, Michnovicz JJ, Bradlow HL (1993) Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation. Biochem Pharmacol 45: 1129–1136.
  • Lai A, Sarcevic B, Chu W, Jernstrom H, Narod SA (2001) Insulin/insulin-like growth factor-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21(WAF1/Cip1). J Biol Chem 276: 25823–25833.
  • Lee AJ, Cai MX, Thomas PE, Conney AH, Zhu BT (2003) Characterization of the oxidative metabolites of 17β-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocriology 144: 3382–3398.
  • Leibelt DA, Hedstrom OR, Fischer KA, Pereira CB, Williams DE (2003) Evaluation of chronic dietary exposure to indole-3-carbinol and absorption-enhanced 3,3‘-diindolylmethane in Sprague-Dawley rats. Toxicol Sci 74: 10–21.
  • Li Y, Li X, Sarkar FH (2003) Gene expression profiles of I3C- and DIM-treated PC3 human prostate cancer cells determined by cDNA microarray analysis. J Nutr 133: 1011–1019.
  • Liu H, Wormke M, Safe SH, Bjeldanes LF (1994) Indolo[3,2- b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity. J Natl Cancer Inst 86: 1758–1765.
  • Michnovicz JJ, Bradlow HL (1990) Induction of estradiol metabolism by dietary indole-3-carbinol in humans. J Natl Cancer Inst 82: 947–949.
  • Safe S (2001) Molecular biology of the Ah receptor and its role in carcinogenesis. Toxicol Lett 120: 1–7.
  • Sanders R (1998) Chalk up another for broccoli! Chemical in vegetable shown to halt growth of breast cancer. News Release: [www.berkeley.edu/news/media/ releases/98legacy/02_20_98a.html].
  • Sanderson JT, Slobbe L, Lansbergen GW, Safe S, van den Berg M (2001) 2,3,7,8-Tetrachlorodibenzo-p-dioxin and diindolylmethanes differentially induce cytochrome P450 1A1, 1B1, and 19 in H295R human adrenocortical carcinoma cells. Toxicol Sci 61: 40–48.
  • Sonnenschein C, Soto AM, Fernandez MF, Olea N, Olea– Serrano MF, Ruiz-Lopez MD (1995) Development of a marker of estrogenic exposure in human serum. Clin Chem 41: 1888–1895.
  • Spink DC, Spink BC, Cao JQ, DePasquale JA, Pentecost BT, Fasco MJ, Li Y, Sutter TR (1998) Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis 19: 291–298.
  • Tiwari R, Guo KL, Bradlow HL, Telang NT, Osborne MP (1994) Selective responsiveness of human breast cancer cells to indole-3-carbinol, a chemopreventive agent. J Natl Cancer Inst 86: 126–131.
  • Zava DT, Blen M, Duwe G (1997) Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture. Environ Health Perspect 105 (Suppl 3): 637–645.

Typ dokumentu

Bibliografia

Identyfikatory

Identyfikator YADDA

bwmeta1.element.agro-article-071a021e-9b77-4dac-910e-e54299f23793
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.